The expression level of Beclin-1 in breast cancer cells was detected by Choi et al., which found that the negative rate of Beclin-1 was 70.1%, the weak positive rate was 26.2%, and the positive rate was only 3.7% [43]. Here, BECN1 is linked to breast carcinoma.